James M. Thorburn
2019 - Twist Bioscience Corp
In 2019, James M. Thorburn earned a total compensation of $3.1M as Chief Financial Officer at Twist Bioscience Corp, a 105% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $213,035 |
|---|---|
| Option Awards | $1,415,209 |
| Salary | $384,167 |
| Stock Awards | $1,039,793 |
| Total | $3,052,204 |
Thorburn received $1.4M in option awards, accounting for 46% of the total pay in 2019.
Thorburn also received $213K in non-equity incentive plan, $384.2K in salary and $1M in stock awards.
Rankings
In 2019, James M. Thorburn's compensation ranked 4,017th out of 13,971 executives tracked by ExecPay. In other words, Thorburn earned more than 71.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,017 out of 13,971 | 71st |
Division Manufacturing | 1,451 out of 5,695 | 75th |
Major group Chemicals And Allied Products | 510 out of 2,194 | 77th |
Industry group Drugs | 430 out of 1,880 | 77th |
Industry Biological Products, Except Diagnostic Substances | 90 out of 389 | 77th |
Source: SEC filing on January 7, 2021.
Thorburn's colleagues
We found two more compensation records of executives who worked with James M. Thorburn at Twist Bioscience Corp in 2019.
News
Twist Bioscience Corp CEO Emily Leproust's 2022 pay jumps 362% to $5.9M
January 6, 2023
Twist Bioscience Corp CEO Emily Leproust's 2021 pay falls 83% to $1.3M
January 4, 2022
Twist Bioscience Corp CEO Emily Leproust's 2020 pay slips 8% to $7.4M
January 7, 2021
Twist Bioscience Corp CFO James Thorburn receives $1.5M in 2018
June 14, 2019